Genetic & Genomic MedicineJournal of Clinical ImmunologyPeer-reviewed
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome
David H. McDermott, Shamik Majumdar, Daniel S. Velez…·Philip M. Murphy
This study evaluates continuous subcutaneous plerixafor infusion in WHIM syndrome patients, showing improved leukocyte counts, wart regression, and patient preference over daily injections.
DOI 10.1007/s10875-026-02010-4